抗苗勒管激素作为卵巢储备标志物对绝经前女性非酒精性脂肪性肝炎存在与严重程度的保护作用
基于NASH临床研究网络,分析绝经前女性肝活检6个月内抗苗勒管激素(AMH)水平与NAFLD组织学指标的关系。校正混杂因素后,较高AMH四分位与NASH患病、NAFLD活动评分≥5、Mallory透明小体及纤维化分期升高呈负相关,在无多囊卵巢综合征女性中更明显。
要点
- 较高AMH四分位与绝经前女性NASH患病风险降低相关(AOR 0.64,95%CI 0.41-1.00)。
- 较高AMH四分位与NAFLD活动评分≥5风险降低相关(AOR 0.52,95%CI 0.35-0.77)。
- 无多囊卵巢综合征女性中AMH保护效应更明显,NASH的AOR为0.53(95%CI 0.32-0.90)。
核心结论
- AMH可能反映绝经前女性NASH的独特生物标志物,研究结果提示生殖衰老与女性NAFLD组织学严重程度之间存在新关联。
研究设计与样本
- 利用NASH临床研究网络,纳入绝经前女性,分析肝活检6个月内AMH水平与NAFLD组织学指标的关联。
- 队列中位年龄35岁,73%为白人,24%为西班牙裔,33%有糖尿病,81%有肥胖,95%有血脂异常。
- 校正年龄、种族/民族、胰岛素抵抗稳态模型评估、体重指数、血脂异常、多囊卵巢综合征、雌激素-孕激素使用及月经周期性的回归模型。
主要发现
- 活检时71%有NASH,68%有任何纤维化,15%有晚期纤维化。
- 校正分析(n=205)中,较高AMH四分位与NASH患病负相关(AOR 0.64,95%CI 0.41-1.00)。
- 较高AMH四分位与NAFLD活动评分≥5负相关(AOR 0.52,95%CI 0.35-0.77)。
- 较高AMH四分位与Mallory透明小体负相关(AOR 0.54,95%CI 0.35-0.82),与更高纤维化分期负相关(AOR 0.70,95%CI 0.51-0.98)。
- 无多囊卵巢综合征女性(n=164)中,较高AMH四分位与NASH负相关(AOR 0.53,95%CI 0.32-0.90),与任何NASH纤维化负相关(AOR 0.54,95%CI 0.32-0.93)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Antimüllerian hormone (AMH) is a marker of ovarian reserve with emerging data linking lower levels to some metabolic and inflammatory diseases in women. Whether AMH levels influence nonalcoholic fatty liver disease (NAFLD) is unknown. METHODS: Leveraging the NASH Clinical Research Network we determined the association of AMH levels within 6 months of liver biopsy with presence and severity of histologic measures of NAFLD in premenopausal women. Outcomes included presence of nonalcoholic steatohepatitis (NASH), presence and severity of fibrosis, and NAFLD Activity Score and its components. Logistic and ordinal logistic regression models were adjusted for age, race/ethnicity, homeostatic model assessment for insulin resistance, body mass index, dyslipidemia, polycystic ovary syndrome, estrogen-progestin use, and menstrual cyclicity. RESULTS: Median cohort age was 35 years; 73% were white and 24% Hispanic. Thirty-three percent had diabetes, 81% had obesity, and 95% had dyslipidemia. On biopsy 71% had NASH, 68% had any fibrosis, and 15% had advanced fibrosis. On adjusted analysis (n = 205), higher AMH quartiles were inversely associated with NAFLD histology including prevalent NASH (adjusted odds ratio [AOR], 0.64; 95% confidence interval [CI], 0.41-1.00), NAFLD Activity Score ≥5 (AOR, 0.52; 95% CI, 0.35-0.77), Mallory hyaline (AOR, 0.54; 95% CI, 0.35-0.82), and higher fibrosis stage (AOR, 0.70; 95% CI, 0.51-0.98). The protective effects of AMH were more pronounced among women without polycystic ovary syndrome (n = 164), including lower odds of NASH (AOR, 0.53; 95% CI, 0.32-0.90) and any NASH fibrosis (AOR, 0.54; 95% CI, 0.32-0.93). CONCLUSIONS: AMH may reflect a unique biomarker of NASH in premenopausal women and findings suggest a novel link between reproductive aging and histologic severity of NAFLD in women.
引用
- Maldonado SS, Cedars MI, Yates KP, et al. Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women. Clin Gastroenterol Hepatol. 2023. PMID: 37678489. doi:10.1016/j.cgh.2023.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。